Please login to the form below
managed access programmes
This page shows the latest managed access programmes news and features for those working in and with pharma, biotech and healthcare.
Clinigen acquires Idis for £225m
Idis supplies unlicensed medicines predominantly on an exclusive basis through managed access programmes as well as on demand via its general access division.
Latest news
-
Langland triumphs at IPA Best of Health Awards
In addition to picking up Best of Show, Langland's campaign for Idis – which develops managed access programmes – also won Best use of Art Direction and a Gold Award for Healthcare
-
Langland leads Global Award winners
I did this with Idis', an international campaign, was built around a series of documentary films designed to raise awareness of Idis' managed access programmes.
More from news
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
Managed Access Programmes: a powerful source of real-world insight
Managed Access Programmes' (MAP) primary objective is to provide treatment for patients with unmet medical needs who cannot get access via a clinical trial to an investigational product which is not ... Moreover, the FDA reviewed the Expanded Access
-
Managed Access Programmes: a powerful source of real-world insight
Managed Access Programmes' (MAP) primary objective is to provide treatment for patients with unmet medical needs who cannot get access via a clinical trial to an investigational product which is not ... Moreover, the FDA reviewed the Expanded Access
-
10 ways to optimise patient access through the product life cycle with Managed Access Programmes
So enabling and maintaining access for patients indeed should be a strategic imperative from top management down. ... Companies should start thinking about Managed Access Programmes (MAPs) as early as possible in the transition from drug development to
More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest appointments
-
Former Quintiles president Jeff Thomis to chair Idis
Will oversee company’s activities to develop managed access programmes for medicines. ... Idis has appointed Jeff Thomis as chairman to oversee the company's activities in creating managed access programmes for medicines.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Sanofi Global Health unveils new nonprofit Impact brand
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- Pfizer announces commitment to achieve Net-Zero Standard by 2040
- Novartis announces positive phase 3 trial results for advanced oesophageal cancer
- The Power of AI in Medical Education
- First evidence-based guide launched to put patients at heart of digital innovations
- FDA grants Priority Review for Biogen and Eisai’s lecanemab for early Alzheimer’s disease
- New Swiss research reveals how Omicron evades the immune system
- Evoke Kyne Named Communiqué Communications Consultancy of the Year 2021
- Michael Grela Elected President of the Society for Health Communication
- First evidence-based guide launched to put patients at heart of digital innovations
- Roche shares new positive Ocrevus data for MS patients
- FDA grants Priority Review for Biogen and Eisai’s lecanemab for early Alzheimer’s disease
- A creative awakening – how pharma is bringing innovation to the patient journey
- Country report: The healthcare market in South Korea
- European Commission approves potential new treatment for Pompe disease
PMHub
AMICULUM
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...
Latest intelligence
- Five big changes in the healthcare comms landscape
- The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
- Early communications in Pharma: How effective pre-approval comms delivers launch success
- What communications are required for a successful launch...
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
